Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma.

Saved in:
Bibliographic Details
Title: Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma.
Authors: Massey AJ; Vernalis (R&D) Ltd, Cambridge, UK., Benwell K; Vernalis (R&D) Ltd, Cambridge, UK., Burbridge M; Institut de Recherches Servier, Croissy-sur-Seine, France., Kotschy A; Servier Research Institute of Medicinal Chemistry, Budapest, Hungary., Walmsley DL; Vernalis (R&D) Ltd, Cambridge, UK.
Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Nov; Vol. 25 (22), pp. 10650-10662. Date of Electronic Publication: 2021 Oct 28.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1582-4934
DOI:10.1111/jcmm.17002